INTRODUCTION
Azoospermia affects approximately 1% of the male population, accounts for over 15% of all male infertility, [1] [2] [3] and includes genital tract obstruction (obstructive azoospermia) and spermatogenic impairment (nonobstructive azoospermia, NOA). 4, 5 NOA is mainly caused by severely impaired spermatogenesis and is reported to account for more than 70% of azoospermia in Korean patients. 6 Chromosomal abnormalities, such as Klinefelter syndrome, balanced chromosomal rearrangements, and Yq microdeletions, are well known genetic causes of NOA. 7 In many cases, the genetic etiology remains unknown. Matzuk and Lamb 8 reviewed many genes involved in spermatogenesis and mutations in some of those genes were identified in patients with NOA. [9] [10] [11] The stromal antigen 3 (STAG3) gene was mapped to chromosome 7 and consists of 34 exons encoding a protein involved in the meiotic cohesion complex. 12 Human STAG3 is highly expressed in the testis and
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DNA extraction
Genomic DNA was isolated from peripheral blood of the patient and control samples with the QuickGene DNA blood kit (KURABO industries, Neyagawa, Japan), according to the manufacturer's instructions. DNA yield was quantified with the NanoDrop™ spectrophotometer (Thermo Scientific, Wilmington, DE, USA). The extracted DNA was stored at −80°C until further analysis.
Polymerase chain reaction
Coding regions of STAG3 (NM_001282716.1) were amplified for genetic screening by polymerase chain reaction (PCR), using primers for the 34 exons and their intron boundaries that were designed by Primer 3 (http://primer3.ut.ee). As this gene has multiple pseudogenes, we performed long-range PCR that produced eleven fragments and designed eleven primer pairs to cover the 34 exons and avoid pseudogene sequences. The locations and sequences of primer sets are presented in Supplementary Table 1 .
Sequencing analysis
All eleven PCR products were purified with ExoSAP-IT (USB Corporation, Cleveland, OH, USA). To sequence the eleven fragments, we designed 30 sequencing primers to cover 34 exons (Supplementary Table 1 ). All the samples were amplified by PCR and sequenced bidirectionally using the BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Austin, TX, USA) and BigDye® X-Terminator™ solutions (Applied Biosystems, Bedford, MA, USA) with standard conditions. The sample supernatant was loaded on the ABI 3130XL Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) and processed with a BigDye® X-Terminator run module. All assays were repeated once for confirmation and the results matched over 99.0%.
Statistical analyses and database search
For each sequence variation, the data were statistically analyzed with Statistical Package for the Social Sciences software (SPSS version 22, IBM Software Group, Chicago, IL, USA). To evaluate the association between patient and control groups, odds ratios (OR), 95% confidence intervals (95% CI), and the applied P values were calculated from both the Chi-squared test and Fisher's exact test (two-tailed). Applied P < 0.05 were considered statistically significant. Three databases, Polyphen-2, SIFT, and Mutation Tester, were used to predict potentially damaging effects due to amino acid changes. Multiple hypothesis testing was performed with the Benjamini-Hochberg method 23 to control false discovery rate (FDR) in the logistic regression analysis. Calculating the FDR is a way to address problems associated with multiple comparisons, and FDR provides a measure of the expected proportion of false-positives in the data.
Haplotype block structure was established by HaploView 4.1 software (https://www.broadinstitute.org) using the method of block definition of Gabriel et al. 24 Haplotype association tests were also conducted with this software.
Molecular cloning
The entire 3'-untranslated region (3'-UTR) of STAG3 was amplified from genomic DNA, which contained the rs1052482 A or T alleles, using primers that included SacI and XbaI restriction sites. Primer sequences of the STAG3 3'-UTR were: forward: 5'-GAGCTCccgttgctgtgtcctgtgta, reverse: 5'-TCTAGAgaccaagaacctgacctcca (for a predicted 476 bp product). PCR products were cloned into the pmirGLO vector (Promega, Madison, WI, USA) via the SacI and XbaI sites and all constructs were verified by DNA sequencing.
Dual luciferase assay
HEK293T cells were seeded in 48-well plates (3 × 10 4 per well). After 24 h, 200 ng pmir-rs1052482A, pmir-rs1052482T, or pmir-empty vector was transiently transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). The Renilla vector was used as an internal (Figure 2c) . The data indicate that miR-3162-5p targets the rs1052482A sequence more efficiently than that of rs1052482T.
DISCUSSION
Many autosomal genes such as ring finger protein 212 (Rnf212), testis expressed 15 (Tex15), syntaxin 2 (Stx2), and siah E3 ubiquitin protein ligase 1A (Siah1a) are reported to be crucial factors for the meiotic process and spermatogenesis in mouse studies. [25] [26] [27] [28] Human homologs of these genes also play a role in meiosis, and variations of these genes are thought to induce spermatogenic impairment. 8, [29] [30] [31] In recent studies, the homologous deletion of Stag3 has been shown to induce sterility associated with the premature arrest of meiotic prophase I in both male and female mice.
18,32 Therefore, we have investigated the association between STAG3 gene variations and male infertility.
We identified 30 variations in the coding regions and intron boundaries of STAG3 in patients with NOA and in control samples. Of the 30 variations, seven were exonic and three were found only in different infertile patients. For these variations, we evaluated the potential pathogenic effects by three prediction methods, Polyphen-2, SIFT, and Mutation Taster ( Table 4) . Most variations (six of nine) were considered benign and three variations did not show consistent results in the three predictive programs. Minor allele frequencies (MAFs) of these variations were not significantly different between patients and controls, and these MAFs were similar to those of other Asian populations on the NCBI SNP database from the 1000 Genomes Project. Considering these data, the above-mentioned variations are unlikely to be related to the spermatogenic impairment in our control for transfection efficiency. After 48 h, the transfected cells were harvested and lysed with a dual-luciferase reporter assay system (Promega), and the activities of Firefly and Renilla were measured in a Luminometer, Centro XS LB960 (Berthold Technologies, Bad Wildbad, Germany), and MikroWin2000 software (https://mikrowin-20001. software.informer.com). Transfection experiments were performed in triplicate, and activity measurements were done for three times. Relative luciferase activity was determined by normalizing firefly luciferase activity against Renilla luciferase activity. An average value of firefly/Renilla was calculated and then normalized to the average value of the empty vector to yield the vector-normalized ratio.
MicroRNAs (miRNAs)
Computational prediction of putative targets for STAG3 mRNA was performed by searching mirmap.ezlab.org, www.targetscan.org, www. microrna.org, and www.mirdb.org for the target prediction algorithms. From the potential miRNAs interacting with STAG3 mRNA 3'-UTR, we selected seven candidate miRNAs (miR-148a, miR-2909, miR-3162-5p, miR-33a-5p, miR-33b-5p, miR-4739, and miR-6508-3p) that allowed rs1052482A or T alleles to be included in the seed sequence. 
RESULTS
Thirty single-nucleotide variations (SNVs) in STAG3 were identified in this study. The locations, types, frequencies, and P values of the variations are presented in Supplementary Table 3 . The distributions of genotypes of all the SNVs followed the Hardy-Weinberg equilibrium in patients and controls. Seven were exonic, 18 were intronic, one was in the 5'-UTR, and four were in the 3'-UTR of the 30 variations. Three exonic variants were nonsynonymous and the other four variants were synonymous. Three variants were found in a patient but not in controls (c.1269C>T p.Asp423, +112G>A, +315C>T); two variants, c.3669+35C>G and +198A>T, showed significant differences in the frequency between patient and control groups (P = 0.021, OR: 1.79, 95% CI: 1.098-2.918). Haplotype analysis by HaploView 4.1 showed that nineteen variants were separated into five linkage disequilibrium (LD) blocks (Figure 1 ). As shown in Table 2 , in particular, the frequencies of G-C-A (case: control = 0.504: 0.606, P = 0.009), G-G-T (case: control = 0.162: 0.075, P < 0.001), and C-C-A (case: control = 0.075: 0.018, P < 0.001) haplotypes in block 5 were significantly different between patients and controls. Table 3 shows a genetic model of the 3 SNVs (rs2246713, rs1727130, and rs1052482) between the cases and the controls. We found that the individuals with the CG genotype of rs1727130 and AT genotype of rs1052482 had an increased risk susceptibility to NOA in the codominant model, and those with the minor allele G of rs1727130 and T of rs1052482 had an increased risk susceptibility to NOA in the dominant model (P = 0.039, OR: 1.64, 95% CI: 1.030-2.608).
To determine whether variations in the 3'-UTR region affected miRNA-mediated gene expression regulation, miRNAs predicted to interact with STAG3 were examined by in silico analysis, and seven miRNAs, miR-148a, miR-2909, miR-3162-5p, miR-33a-5p, miR-33b-5p, miR-4739, and miR-6508-3p, were found potentially to interact with the 3'-UTR of STAG3 mRNA. The effect of these seven miRNAs on +198A>T variation (rs1052482) was examined by a luciferase assay. Korean male population. Interestingly, two variations, c.3669+35C>G and +198A>T (rs1727130 and rs1052482) located in 3'-UTR, had a significantly different frequency between the patient and control groups. However, there is a discrepancy in this result. According to Yu et al., 33 there is no significant difference in the frequencies of allele and genotype at SNP rs1052482 between patients with NOA and controls and they suggested that this SNP is not associated with azoospermia.
Two variants of rs1727130 and rs1052482 are close together (372 bp apart) and tightly linked, as shown in the LD block analysis. The allele distribution of 2 SNVs between the patient and control groups is more evident in the LD block analysis. On the basis of the data, we propose that multiple SNVs linked to a block can interact with each other to regulate gene function, rather than allowing each SNV to function independently. The presence of SNVs in the 3'-UTR of genes may interfere with mRNA stability and translation through effects on polyadenylation and regulatory protein-mRNA and miRNA-mRNA interactions, or may locally alter secondary structures of mRNAs, affecting the accessibility of binding sites for interacting transelements. [34] [35] [36] We investigated whether rs1052482, the SNV in the 3'-UTR of STAG3, could affect interaction with miRNAs and thus affect posttranscriptional repression of STAG3. When pmir-rs1052482A was cotransfected with miR-3162-5p, a substantial decrease was observed in luciferase activity compared with pmir-rs1052482T. This result suggests that rs1052482 is located within a binding site for miR-3162-5p in the STAG3 3'-UTR, and the minor rs1052482T allele may offset the inhibition by miR-3162-5p.
According to Fukuda et al., 17, 37 STAG3 interacts with the three different α-kleisin subunits present in mammalian meiotic cells, depending on the temporal and spatial distribution. STAG3 combined with meiotic recombination protein (REC8), one of the α-kleisin subunits, and promoted synapsis between homologous chromosomes, while the same complexes inhibited synaptonemal complex assembly between sister chromatids. Therefore, we hypothesize that STAG3 with the rs1052482T variation reduces the normal inhibitory function of mir-3162-5p, thereby increasing the amount of STAG3 protein and ultimately disturbing synapses between homologous chromosomes or sister chromatids. However, it is unclear how elevated STAG3 may affect meiotic chromosome dynamics. In previous studies, mir-3162-5p was identified as a regulator of prostate or cervical antigen in cell carcinomas. [38] [39] [40] However, little is known about mir-3162-5p's regulation of human meiosis, because of the difficulties in uncovering the spatiotemporal and sequential expression of miRNAs in human germ cells, and identifying which miRNAs are the actual operators for the onset of meiosis or spermatogenesis.
CONCLUSION
We have identified 30 SNVs of STAG3 in the Korean population. Pathogenic variations that directly cause NOA were not identified. However, we found that two SNVs, rs1727130 and rs1052482, located in the 3'-UTR region may be associated with the NOA phenotype through the regulation of miRNA. Further studies are needed to determine whether variations in the 3'-UTR region of STAG3 actually affect gene expression through miRNAs, including mir-3162-5p in germ cells. While there is still much to learn about the exact mechanisms regulating human meiosis or spermatogenesis, our findings contribute to the understanding of spermatogenic impairment, as well as the identification of predictive susceptibility biomarkers.
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Supplementary
P1 Exon1 (404bp) F CGCCCAATGGAGTAGGAGAT Exon1 (404bp) F CGCCCAATGGAGTAGGAGAT R ACCTGTCAGAGCCTGGAAGA R ACCTGTCAGAGCCTGGAAGA P2 Exon2-Exon5 (7,413bp) F TACCACACCCAGTGTGCAAT Exon2 (294bp) F GCCCTTTCTTCTCTTTCTTCC R GGGGGTACCACAGCTACAGA R TCCCACGCATATTATCATCAA Exon3 (394bp) F AAAAAGACTTTGTCCCAACTTCC R CGGCTCACTGCAAGCTCT Exon4 (538bp) F GGTTCAGGTGATACGGTTCAT R TGTTCACGTCAAATCAAGTTTGT Exon5 (450bp) F TTGTTTACCTCCCAGGGTTG R AGTGCCCGGCCTAAATAAGT P3 Exon6-Exon8 (7,971bp) F CTTATTGCCATGGCTTCGTT Exon6 (297bp) F CCCACCTAAGCTCTTTGCAG R CCTGTGGCACATTTTGGTAA R TTCCTCCTTCTAAAAGCTACCC Exon7 (365bp) F GCCCCTATGACTTCATGGAC R AGCCAAGATGCAGGTAGGAA Exon8 (395bp) F TCATTGCCCTTCTTTCCTTC R ACCCCTTACAGGATGGGTCT P4 Exon9-Exon13 (3,748bp) F TCCGAATAACCACATGCAGA Exon9 (330bp) F CGGGGGTTCACACTATCCTA R GCTCAGCACAACAGGAAACA R ATTTTTGCTCCAGCTGCATT Exon10 (433bp) F CCATGAGAGGGAGTTATCTGG R CTCCCCGTACCTCAGGTTTT Exon11 (300bp) F AATGAGGGATCGGAGAGG R GCTGGGATAGCCAAGACATC Exon12 (399bp) F TCTTGGCTATCCCAGCATCT R CCCCCTCAACATACTGCAAC Exon13 (425bp) F TGCAGTATGTTGAGGGGGTA R GCTGCGAGAAGAAAGGAGAC P5 Exon14-Exon17 (1,893bp) F ATCTGCTGCTGCCCTACCTA Exon14 (417bp) F TCTCCCTGGTGTCTCCTTTC R AAGCAGCTGAGAAGCTGGAG R AGGCTGGTCTCAAACTCCTG Exon15 (352bp) F AATGGAGAAGGATGGGAGTG R CACCTTCCAACTCCAAGCTC Exon16 (460bp) F TGCTGGAGAAGGACCAGAGT R TGCTGGGATTATAGGCGTAA Exon17 (400bp) F AAATCTCGTGGGAGCTACTGA R AAGCAGCTGAGAAGCTGGAG P6 Exon18-Exon21 (1,082bp) F GGGGGTGGGAGTAGGAATTA Exon18 (248bp) F GGGGGTGGGAGTAGGAATTA R CTTCCTCGCTTTGTCCACTC R GGAACCCAAGTTCTTAGGAAAAA Exon19 (387bp) F AATGCTTTTAACCCCGTTCC R CAATAGCATTTCCCCCAGAA Exon20~21 (526bp) F AGCAGGAGCTTGAAGAGCTG R CTTCCTCGCTTTGTCCACTC P7 Exon22-Exon25 (1,237bp) F GAGTGGACAAAGCGAGGAAG Exon22~23 (553bp) F GATGCCTCTGAAGAATGTCCA R TTGGATATCCCCCACCTGTA R AAAAGCCTGTAGGGGGAAAA Exon24~25 (626bp) F GGAGCAACAAGGCGAGTATC R TTGGATATCCCCCACCTGTA P8 Exon26-Exon29 (1,565bp) F TTATTTTGGGCTTTGCACCT Exon26 (344bp) F GGAGTTTGGGAGGGAGACAT R TACCCACACACAGCACCCTA R AAGAATGAAGGAACCTATCACG Exon27 (371bp) F CAAGGCCTTTGGAATTTCTG R AAGGCATACCCACCCCTAAC Exon28~29 (602bp) F GGGTATGCCTTTGGAGACAA R CCCTGAATGACAGTAGATGCTC P9 Exon30-Exon32 (2,057bp) F AGCCCAGGGGTATGTCTCTT Exon30 (427bp) F TAGGGCTATGCCCATTTGAG R GGAGGATAGGGGGTCATGTT R ACAGCAGGGAACCATGAAAC Exon31 (387bp) F CTCCCACATTGTTGGGTTCT R TGACAGGAAGTGCTCTGTGG Exon32 (394bp) F CTCACCCATTGCCTCTCTGT R TCTAGATTCATTCAGCTTTTCCA Supplementary
